Bouncebackability portends increased risk of adverse outcomes in RA
Dr. Richard Conway discusses Abstract 2218 at ACR22 Convergence.
Abstract 2218: Frailty Is Associated with Serious Infections in Biologic and Targeted-synthetic DMARD Treated Patients with Rheumatoid Arthritis
Deucravacitinib in PsA
Dr. Arthur Kavanaugh discusses abstract 1598 at ACR22 Convergence in Philadelphia.
Abstract 1598: Safety and Efficacy of Deucravacitinib, an Oral, Selective Tyrosine Kinase 2 Inhibitor, in Patients with Psoriatic Arthritis: 52-Week Results from a Randomized Phase 2 Trial
Efficacy and Safety Results from BE OPTIMAL in PsA
Dr. Arthur Kavanaugh discusses abstract L02 ACR22 Convergence in Philadelphia, PA.
L02: Bimekizumab Treatment in Biologic DMARD-Naïve Patients with Active Psoriatic Arthritis: 52-Week Efficacy and Safety Results from a Phase 3, Randomized, Placebo-Controlled, Active Reference Study
Hydroxychloroquine Update from ACR22
Dr. Michelle Petri reviews several abstracts presented at ACR22 Convergence.
Abstracts 0343, 0538, 0976, 0983, 0981, 0980
RA: Steroids are bad, again
Dr. Richard Conway discusses Abstract 2219 at ACR22 Convergence
Abstract 2219: Time-Dependent Evaluation of Glucocorticoid Exposure Duration and Major Adverse Cardiovascular Events in a Cohort of Veterans with Rheumatoid Arthritis
Tapering TNFi in nonradiographic AxSpA
Dr. Peter Nash at ACR22 Convergence in Philadelphia, PA.
Tofacitinib and RA-ILD
Dr. Richard Conway discusses Abstract 2251 at ACR22 Convergence.
Abstract 2251: Reduction in Rheumatoid Arthritis-Associated Interstitial Lung Disease Risk in Patients Treated with Tofacitinib
Life or Organ Threatening SLE: What To Do? Is There Anything New?
Dr. Michelle Petri discusses Abstracts 1651, 1677 at ACR22 Convergence in Philiadelphia, PA.
Voclosporin and Steroids in Lupus Nephritis
3 Big Lupus Themes from EULAR 2024
Does B Cell Depletion Matter?
Do MRI changes at the Spine and SI Joints in Treatment of AxSpA Matter?
Do we need more IL-17 and JAK Inhibitors in Spondyloarthritis?
Do we need more IL-17 and JAK Inhibitors in Spondyloarthritis?
Is Cannabis Safe? (6.7.2024)
ACR’s Run at Goliath (PCPs) (5.31.2024)
The Window of Opportunity (5.24.2024)
Don't You Know Who I am (5.17.2024)
My Cancelled Lecture (5.11.2024)
Roadblocks to reaching remission in lupus Sponsored by GSK US Medical Affairs
Featured BSR Abstracts (5.3.2024)
SLE Faculty Panel Q&A - Featuring Drs. David Karp, Michelle Kahlenberg, and Andrea Fava; moderated by Dr. Jack Cush
Tuesday Night Rheumatology- Mastering SLE
Current & Future Biomarkers in SLE - Dr. Andrea Fava
Rheum Chapter Notes (4.26.2024)
Spondyloarthritis Faculty Panel Q&A - featuring Drs. Eric Ruderman, Lihi Eder, and Lianne Gensler; moderated by Dr. Artie Kavanaugh
Tuesday Night Rheumatology- Spondyloarthritis Spectrum
Nonradiographic Axial Spondyloarthritis - Dr. Eric Ruderman
Create your
podcast in
minutes
It is Free
Good Mood Revolution
Good Nurse Bad Nurse
The Relaxback UK Show
On Call With Dr. Anselm Anyoha
The Doctor’s Farmacy with Mark Hyman, M.D.
The Peter Attia Drive